Bayer Aktiengesellschaft logo

Bayer Aktiengesellschaft

TickerBAYN.DEVenueXETRASectorHealthcarePrimary listingBeta0.83
€43.40-2.38%
FinScore60

Bayer Aktiengesellschaft is a Germany-based company in the Healthcare sector with a market capitalisation of $49.1B. Its FinScore is 60/100; its highest-scoring layer is Quality (80) and its lowest is Growth (25).

Market cap
$49.1B
P/E (TTM)
n.m.
Negative TTM earnings
Dividend yield (TTM)
0.25%
ROE
-6.1%

Share price performance

Loading chart…

About Bayer Aktiengesellschaft

www.bayer.com

Bayer Aktiengesellschaft operates as a life science company in Europe, the Middle East, Africa, Germany, Switzerland, North America, the United States, the Asia Pacific, China, Latin America, and Brazil. It operates through Pharmaceuticals, Consumer Health, and Crop Science segments. The Pharmaceuticals segment provides prescription products primarily for cardiology and women’s health care; specialty therapeutics in the areas of oncology, hematology, and ophthalmology; and diagnostic imaging equipment and contrast agents, as well as cell and gene therapy. The Consumer Health segment offers nonprescription over-the-counter medicines for self-medication and self-care; nutritional supplements; allergy, cough, and cold; dermatology; pain and cardiovascular risk prevention; and digestive health products. The Crop Science segment offers chemical and biological crop protection products, improved plant traits, seeds, digital solutions, and pest and weed management products, as well as customer services for agriculture. It also engages in the breeding, propagation, and production/processing of seeds, including seed dressing. The company distributes its products through wholesalers, pharmacies and pharmacy chains, supermarkets, online and other retailers, and hospitals, as well as directly to farmers. Bayer Aktiengesellschaft was founded in 1863 and is based in Leverkusen, Germany.

Profile
Sector
Healthcare
Industry
Drug Manufacturers - General
HQ
Germany
Fiscal year-end
December
Trading currency
EUR
Reporting currency
EUR
Fundamentals updated
70 days ago
Market
Market cap
$49.1B
Shares outstanding
982.4M
Dividend yield (TTM)
0.25%
Beta (issuer)
0.84
Revenue (latest FY)
€45.6B

Revenue breakdown

Revenue split not available

FinScore

As of 2026-10-19
Overall60
Quality80
Growth25
Value69
Momentum62
Relative Strength54

Snapshot

Ownership

As of 2026-03-31
Institutional
0.0%
Insider
—
Free float
100.0%
Top-1 institutional holders
0.0%
Shares outstanding
982.4M
Sign up to see the top holders

Sign up or log in to see Analysis

Analysis for Bayer Aktiengesellschaft is available to Finryse members. The Overview stays open to everyone; creating an account is free.

Sign up or log in to see Financials

Financials for Bayer Aktiengesellschaft is available to Finryse members. The Overview stays open to everyone; creating an account is free.

Sign up or log in to see Estimates

Estimates for Bayer Aktiengesellschaft is available to Finryse members. The Overview stays open to everyone; creating an account is free.

Sign up or log in to see Peers

Peers for Bayer Aktiengesellschaft is available to Finryse members. The Overview stays open to everyone; creating an account is free.

Sign up or log in to see Valuation

Valuation for Bayer Aktiengesellschaft is available to Finryse members. The Overview stays open to everyone; creating an account is free.

Sign up or log in to see News

News for Bayer Aktiengesellschaft is available to Finryse members. The Overview stays open to everyone; creating an account is free.